Pathophysiology of erythema multiforme;Physiopathologie de l'erytheme polymorphe

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 11, 1998, Pages 799-805

  Barbaud, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHEMA MULTIFORME; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENITAL HERPES; HERPES SIMPLEX; INFLAMMATION; PATHOLOGY;

DIAGNOSIS, DIFFERENTIAL; ERYTHEMA MULTIFORME; HERPES GENITALIS; HERPES SIMPLEX; HUMANS; INFLAMMATION;

EID: 0031763359     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme : a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol 1983;8:763-75.
2. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau J-C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993, 129:92-6.
3. Assier H, Bastuji-Garin S, Revuz J, Roujeau J-C. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995;131:539-43.
4. Roujeau J-C. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994;102:28s-30s.
5. Côté B, Wechsler J, Bastuji-Garin S, Assier H, Revuz J, Roujeau J-C. Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 1995;131:1268-72.
6. Bystryn J-C. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. (réponse). Arch Dermatol 1996;132:711.
7. Mirowsk GW, Lozada-Nur F, Dekker NP, MacPhail LA, Regezi JA. Altered expression of epithelial integrins and extracellular matrix receptors in oral erythema multiforme. J Cutan Pathol 1996;23:473-8.
8. Howland WW, Golitz LE, Weston WL, Huff JC. Erythema multiforme: clinical, histologic, and immunologic study. J Am Acad Dermatol 1984;10:438-46.
9. Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 1996;135:6-11.
10. Fitzgerald EA, Purcell SM, Kantor GR, Goldman HM. Rowell's syndrome: report of a case. J Am Acad Dermatol 1996;35:801-3.
11. Tay Y-K, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (von Hebra). J Am Acad Dermatol 1996;35:757-60.
12. Imafuku S, Huang S, Burnet JW, Aurelian L. T cell repertoire usage in herpes simplex infections and erythema multiforme. J Invest Dermatol 1995;104:565.
13. Brice SL, Krzemien D, Weston WL, Huff JC. Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme. J Invest Dermatol 1989;93:183-7.
14. Kazmicrowski JA, Peizner DS, Wuepper KD. Herpes simplex antigen in immune complexes of patients with erythema multiforme. JAMA 1982;247:2547-50.
15. Imamura S, Horio T, Yanase K, Taniguchi S, Miyachi Y, Tachibana T, Yoshioka A, Fujita M. Erythema multiforme: pathomechanism of papular erythema and target lesion. J Dermatol 1992;19:524-33.
16. Darragh TM, Egbert BM, Berger TG, Yen TSB. Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol 1991;24:23-26.
17. Imafuku S, Kokuba H, Aurelian L, Burnett J. Expression of Herpes simplex virus DNA fragments located in epidermal keratinocytes and germinative cells is associated with the development of erythema multiforme lesions. J Invest Dermatol 1997;109:550-6.
18. Schofield JK, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br J Dermatol 1993;128:542-5.
19. Tatnall FM, Schofield KK, Proby C, Leigh IM. A double blind placebo controlled trial of continuous acyclovir in recurrent erythema multiforme. Br J Dermatol 1991;125:29s.
20. Chosidow O, Bourgault I, Roujeau J-C. Drug rashes. What are the targets of cell-mediated cytotoxicity ? Arch Dermatol 1994;130:627-9.
21. Barbaud A, Béné M-C, Faure GC. Immunological physiopathology of cutaneous adverse drug reactions. Eur J Dermatol 1997;7:319-23.
22. Zohdi-Mofid M, Horn TD. Acrosyringeal concentration of necrotic keratinocytes in erythema multiforme: a clue to drug etiology, clinicopathologic review of 29 cases. J Cutan Pathol 1997;24:235-40.
23. Friedmann PS, Stricklaand I, Pirmohamed M, Park K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994;130:598-604.
24. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Piérard GE. Macrophages and tumor necrosis factor a in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-8.
25. Paquet P, Piérard GE. Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 1997;19:127-32.
26. Hertl M, Bohlen H, Jugert F, Boecker C, Knaup R, Merk HF. Predominance of epidermal CD8 + T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J. Invest Dermatol 1993;101:794-9.
27. Hertl M, Merck HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995;105:95s-8s.
28. Moncada B, Delgado C, Quevado MA. Abnormal T-cell response in toxic epidermal necrolysis. Arch Dermatol 1994;130:116.
29. Inachi S, Mizutani H, Shimizu M. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Arch Dermatol 1997;133:845-9.
30. Foedinger D, Sterniczky B, Elbe A, Anhalt G, Wolff K, Rappersberger K. Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. J Invest Dermatol 1996;106:1012-6.
31. Paul C, Wolkenstcin P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau J-C. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996;134:710-4.